6505-00-509-7622 ( NDC00364-1111-01 , NDC00182-0811-01 , NDC00075-2840-01 , NDC00536-4074-01 , NDC00904-0629-60 )

NSN Information
NSN FSC NIIN Item Name INC
6505-00-509-7622 6505 005097622 NIACIN EXTENDED-RELEASE CAPSULES 4259
NSN Features
MRC Parameter Characteristics
CQLS CAPSULE CONTENT FORM ANY ACCEPTABLE
AKJA ACTIVE MEDICAMENT MEDICINAL STRENGTH 250.000 MILLIGRAMS NIACIN ACTIVE INGREDIENT
CQCT PRIMARY CONTAINER TYPE BOTTLE
CXCY PART NAME ASSIGNED BY CONTROLLING AGENCY NIACIN EXTENDED-RELEASE CAPSULES 250MG 100S
AKJC CAPSULE TYPE ANY ACCEPTABLE
CYLZ CAPSULE PRIMARY CONTAINER CONTENT QUANTITY 100.000
Manufacturing Part Numbers (SKUs)
Part SKU Cage Status RNVC RNCC SADC DAC RNAAC
NDC00364-1111-01 64682 R 9 5 6 54
NDC00182-0811-01 63488 A 1 5 4 ZZ
NDC00075-2840-01 04518 A 1 5 4 ZZ
NDC00536-4074-01 4V824 H 9 5 4 54
NDC00904-0629-60 0S8F7 A 2 3 4 54
Manufacturers
Part SKU Cage Manufacturer Type Status
NDC00364-1111-01 64682 SCHEIN HENRY INC F R
NDC00182-0811-01 63488 GOLDLINE LABORATORIES INC. A A
NDC00075-2840-01 04518 AVENTIS PHARMACEUTICALS PRODUCTS A A
NDC00536-4074-01 4V824 RUGBY GROUP INC A H
NDC00904-0629-60 0S8F7 MAJOR PHARMACEUTICALS INC F A
FLIS Identification
PMIC ADPE Code CRITL Code DEMIL Code DEMIL INTG NIIN Asgt ESD HMIC ENAC Schedule-B INC
A X A 1 08/03/1 P 3004505020 4259
FLIS Management
MOE REC Rep Code Mgmt Ctl USC Phrase Code Phrase Statement
VA V K U/I CONTAINS 100 TT
DN 9B----- N R REFER TO NON-STD NON-DMSB REV
DN 9B----- N R REFER TO USV LABS
DF ------- F K U/I CONTAINS 100 EA
DS I K U/I CONTAINS 100 EA
DA C2201X- A K U/I CONTAINS 100 EA
DN 9B----- N K U/I CONTAINS 100 EA
Demilitarization Codes & Management
DML PMI HMIC ADP CC ESDC
A A P X
Miscellaneous Management
MOE (S_A) SOS AAC QUP UI SLC CIIC RC MCC SVC
DF SMS L 1 BT Q U ------- F
DA SMS L 1 BT Q U C2201X- A
DN SMS L 1 BT Q U 9B----- N
VA I 0 BT M U V
DS SMS L 1 BT Q U D
Management Control Army
MATCAT 1 MATCAT 2 MATCAT 3 MATCAT 4 5 ARC
C 2 2 01 X
Freight
NMFC NMFC SUB UFC HMC LTL LCL WCC TCC SHC ADC ACC ASH NMF DESC